Jenkins George M
JENKINS GEORGE M, DIR, reported an open-market or private sale at PALVELLA THERAPEUTICS, INC. involving 3335.000000 shares for an estimated $447585.68. Reported holdings after the transaction were 149228.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 12, 2026
- Filing date
- Oct 14, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 152,563 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PVLA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001104659-26-115916 Common Stock
- Transaction date
- Oct 12, 2026 Filed Oct 14, 2026, 11:14 PM · 2d delay
- Shares
- 3,335 sh $134.21 per share
- Estimated value
- -$447k Computed from shares × price
- Holdings after
- 149,228 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the…
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.91 to $132.9064, inclusive. The Reporting Person undertakes to pro…
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.91 to $133.9078, inclusive. The Reporting Person undertakes to pro…
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.9184 to $134.9182, inclusive. The Reporting Person undertakes to p…
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.9283 to $135.8712, inclusive. The Reporting Person undertakes to p…
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.9387 to $136.8346, inclusive. The Reporting Person undertakes to p…
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.91 to $128.865, inclusive. The Reporting Person undertakes to prov…
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.915 to $129.83, inclusive. The Reporting Person undertakes to prov…
- F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.00 to $130.855, inclusive. The Reporting Person undertakes to prov…
- F10
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.07 to $132.05, inclusive. The Reporting Person undertakes to provi…
- F11
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.07 to $133.045, inclusive. The Reporting Person undertakes to prov…
- F12
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.11 to $134.03, inclusive. The Reporting Person undertakes to provi…
- F13
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.7075 to $121.63, inclusive. The Reporting Person undertakes to pro…
- F14
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.90 to $122.8795, inclusive. The Reporting Person undertakes to pro…
- F15
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.903 to $123.8032, inclusive. The Reporting Person undertakes to pr…
- F16
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.91 to $124.89, inclusive. The Reporting Person undertakes to provi…
- F17
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.99 to $125.84, inclusive. The Reporting Person undertakes to provi…
- F18
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.13 to $127.12, inclusive. The Reporting Person undertakes to provi…
- F19
Eagles Mere Air Museum Foundation.
0 other transactions
0 recent txs